(B38.2) Pulmonary coccidioidomycosis, unspecified

More details coming soon

Icon
1 852 in individuals diagnosis pulmonary coccidioidomycosis, unspecified confirmed

Diagnosis pulmonary coccidioidomycosis, unspecified is diagnosed Women are 35.64% more likely than Men

596

Men receive the diagnosis pulmonary coccidioidomycosis, unspecified

0 (less than 0.1%)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 256

Women receive the diagnosis pulmonary coccidioidomycosis, unspecified

0 (less than 0.1%)

Died from this diagnosis.

Risk Group for the Disease pulmonary coccidioidomycosis, unspecified - Men aged 65-69 and Women aged 0-5

Icon
In Men diagnosis is most often set at age 65-74
Icon
Less common in men the disease occurs at Age 0-64, 75-95+Less common in women the disease occurs at Age 0-1, 5-19, 25-39, 45-54, 60-95+
Icon
In Women diagnosis is most often set at age 0-5, 20-24, 40-44, 55-59

Disease Features pulmonary coccidioidomycosis, unspecified

Icon
Absence or low individual and public risk
Icon

Pulmonary coccidioidomycosis, unspecified - what does this mean

Pulmonary coccidioidomycosis, unspecified is an infection caused by a fungus called coccidioides, which is found in the soil in certain parts of the united states. the infection is spread through inhalation of the fungus, and can cause symptoms such as fever, cough, chest pain, and difficulty breathing. in some cases, the infection can spread to other parts of the body, leading to more serious complications. treatment typically involves antifungal medications.

What happens during the disease - pulmonary coccidioidomycosis, unspecified

Pulmonary coccidioidomycosis is an infection caused by the inhalation of the fungus coccidioides immitis. the fungus can be found in soil in certain areas of the southwestern united states, central america, and south america. inhalation of the fungus leads to an infection in the lungs that can cause an inflammatory response, leading to symptoms such as fever, chest pain, and coughing. in some cases, the infection can spread to other parts of the body, leading to more severe symptoms such as difficulty breathing, joint pain, and skin lesions. treatment typically involves antifungal medications.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Chest X-ray
  • Sputum culture
  • Blood tests
  • CT scan
  • Bronchoscopy
  • Sputum examination
  • Serology test
  • Lung biopsy

Treatment and Medical Assistance

Main goal of the treatment: To reduce the symptoms of Pulmonary Coccidioidomycosis, Unspecified.
  • Administering antifungal medications
  • Providing oxygen therapy
  • Prescribing corticosteroids to reduce inflammation
  • Monitoring the patient's condition and response to treatment
  • Performing chest X-rays to monitor the progression of the disease
  • Providing education on the disease and its management
  • Referring the patient to a specialist if necessary
Icon
4 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Pulmonary coccidioidomycosis, unspecified - Prevention

Pulmonary coccidioidomycosis, unspecified can be prevented by avoiding or minimizing exposure to dust and soil that could contain the fungus, wearing protective masks when working or participating in activities that involve contact with dust, avoiding contact with people who have active infections, and getting vaccinated if available.